FindTrial
Sign In

Metabolic characteristics and major adverse cardiovascular events (MACE) of patients with coronary heart disease (CHD)

Metabolic characteristics and major adverse cardiovascular events (MACE) of patients with coronary heart disease (CHD)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065233
Enrollment
Unknown
Registered
2022-11-01
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

High metabolic risk group:None
Low metabolic risk group:

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Equal to or larger than 18 years old; 2. Diagnosis of CHD by coronary angiography or coronary CTA; 3. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Other sever heart diseases (valvular heart disease, cardiomyopathy, etc.); 2.Respiratory failure or severe liver and renal dysfunction; 3.Acute coronary syndrome caused by non-coronary atherosclerosis (coronary spasm, and myocardial bridge, etc.); 4.Thyroid dysfunction; 5.Adrenal cortical dysfunction; 6.Infection; 7.Tumor; 8.Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events;—

Countries

China

Contacts

Public ContactYang Jianmin

Qilu Hospital of Shandong University

yangjianminsdu@163.com+86 18560086635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026